Regarding the risk of bias, the aim of any research is to have data that can be evaluated and reproduced. However, in their study, there was no table describing the risk of bias for each domain in The Cochrane Collaboration Risk of Bias Tool (CCRBT) for each study included in this review as recommended by Cochrane Group [4] . This table is a must to inform the readers about the studies with a high risk of bias and those with low risk of bias. The ultimate aim is to not overestimate the treatment effect by those at high risk of bias and also supporting other researchers to prioritise those with the lowest risk of bias. Since they were excluding non-published RCTs, their conclusion can not be extrapolated to all RCTs in Saudi Arabia.
Authors requested the local researchers to follow the Consolidated Standards of Reporting Trials (CONSORT) when they submit trials for publication, which is the minimum requirement to ensure more rigorous outcomes. However, they contradict their recommendation by not following the PRISMA--an evidence-based minimum set of items for reporting a systematic review. Authors claim that the local researchers are mostly engaged in explorative types of studies (e.g., cross-sectional). This is unquestionably incorrect and needs more reliable data to confirm such a statement, as an example, we have Saudi researchers had recently published an RCT in a journal with one of the highest impact factor [5] .
In sum, although the authors had worked extensively in one month to finalise a quality check of 61 RCTs about a very sensitive and important topic, the value of their findings is diminished because of all the reasons stated above. With such methodological flaws, it was expected from the authors to write that our conclusion should be interpreted with caution. Indeed, this is just a hidden systematic review with no influence on the outcomes of the randomised control trials in Saudi Arabia.
